Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125346213	12534621	3	F	20160601	20160907	20160706	20160913	EXP		PHHY2016CY092545	NOVARTIS		72.00	YR		M	Y	0.00000		20160913		MD	CY	CY

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125346213	12534621	1	PS	SANDOSTATIN LAR DEPOT	OCTREOTIDE ACETATE	1	Intramuscular	30 MG, QMO							21008	30	MG		/month
125346213	12534621	2	SS	AFINITOR	EVEROLIMUS	1	Oral	10 MG, QD	80	MG	Y	U			0	10	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125346213	12534621	1	Neuroendocrine tumour
125346213	12534621	2	Neuroendocrine tumour

Outcome of event

Event ID	CASEID	OUTC COD
125346213	12534621	DS

Reactions reported

Event ID	CASEID	PT
125346213	12534621	Mouth ulceration
125346213	12534621	Mucosal inflammation
125346213	12534621	Oedema peripheral
125346213	12534621	Wound infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
125346213	12534621	1	20150106		0
125346213	12534621	2	20160525	20160622	0